Intravesical Gemcitabine versus Intravesical Bacillus Calmette–Guérin for the Treatment of Non-Muscle Invasive Bladder Cancer: An Evaluation of Efficacy and Toxicity

BACKGROUND: Intravesical Bacillus Calmette–Guérin (BCG) remains the standard adjuvant treatment for non-muscle invasive bladder cancer (NMIBC) following transurethral resection; however, BCG failure and related toxicities are common. OBJECTIVES: To compare the efficacy and toxicity of intravesical B...

Descripción completa

Detalles Bibliográficos
Autores principales: Prasanna, Thiru, Craft, Paul, Balasingam, Gayathri, Haxhimolla, Hodo, Pranavan, Ganes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673621/
https://www.ncbi.nlm.nih.gov/pubmed/29164059
http://dx.doi.org/10.3389/fonc.2017.00260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673621/
https://www.ncbi.nlm.nih.gov/pubmed/29164059
http://dx.doi.org/10.3389/fonc.2017.00260

Ejemplares similares